Yoga in Depression- A SATYAM Study
- Conditions
- Health Condition 1: null- Patients with Major Depressive Disorder without any Axis I co-morbidity will be studied
- Registration Number
- CTRI/2017/07/009070
- Lead Sponsor
- Department of Science and Technology Govt of IndiaScience And Technology of Yoga And Meditation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Patients:
1.Subjects with DSM IV-TR clinical diagnosis of Major depressive disorder.
2.Severity of depression- moderate to severe and confirmed by a HAMD score >= 18 and absence of hypo/manic symptoms, defined as a YMRS score <= 8.
3.Age 18 â?? 60 years
4.Both sexes
5.Patients who will consent for and be co-operative for yoga therapy.
Healthy subjects:
1.Age from 18 â?? 60 years
2.Both sexes
Patients:
1.Co-morbid substance abuse (excluding nicotine dependence), psychosis, suicidal and self-injurious behavior, mental retardation, any other DSM IV-TR anxiety disorders, OCD and related disorders.
2.Severe depression with catatonic symptoms, suicidal risk or severe psychomotor retardation.
3.Bipolar depression.
4.Subjects with severe physical ailments like general medical conditions like coronary artery disease, fracture, active seizure disorders, auto-immune disorders, recent infection/inflammation as determined by ESR and CRP levels.
5.Subjects having pacemaker or metallic implants.
6.Pregnant, lactating or post-partum women.
7.Ongoing current practice of yoga or any other mind-body techniques (e.g., meditation, Tai-Chi, or related practices) of more than 45 minutes per week on average within the last 6 months or total estimated cumulative prior lifetime practice of more than 100 hours.
8.Those refusing consent.
Healthy subjects:
1.Subjects with any psychiatric disorder as per DSM IV-TR (excluding nicotine dependence).
2.Subjects with severe physical ailments like general medical conditions like coronary artery disease, fracture, active seizure disorders, auto-immune disorders, recent infection/inflammation as determined by ESR and CRP levels.
3.Subjects having pacemaker or metallic implants.
4.Pregnant, lactating or post-partum women.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method